Home » Quality Pro' Salaries on the Upswing, ASQ Salary Survey Says
Quality Pro' Salaries on the Upswing, ASQ Salary Survey Says
Signs of economic turnaround are evident in the quality profession, according to the 24th Annual Salary Survey conducted by Quality Progress (QP), ASQ’s monthly flagship publication.
The overall average salary for U.S. full-time quality professionals is now $85,289, a steady increase from $83,442 in 2009 and $81,064 in 2008. The salary increase is seen this year, just as apparent demand for quality management is surging, as evidenced by ASQ’s online Career Center. For all the survey details, please visit the QP website at www.qualityprogress.com
As in past surveys, 2010 survey results also show that respondents’ salaries increase as their experience in the quality field increases:
- Quality professionals with more than 20 years of experience earned an average of $94,756.
- Professionals with 10 to 20 years of experience earned on average $86,993.
- Those with 10 or fewer years of experience earned on average $71,129.
Specific job categories combined with years of experience also continue to have a significant impact on salary increases. For example, quality managers with more than 20 years of quality experience earn, on average, $4,000 more than managers with 10-20 years of quality experience. These experienced managers (20+ years) also earn over $12,000 more than managers with 10 or fewer years of quality experience.
A first-time comprehensive analysis of the last four years of salary surveys also shows some positive labor trends. Only 3.1 percent of respondents to the 2010 survey said they were unemployed, retired or laid off compared to 4.9 percent of 2009 respondents. More 2010 respondents also reported that their companies didn’t have to make moves such as furloughs, layoffs or hiring freezes to weather the sputtering economy.
Certifications Can Mean Cash
This year, 59 percent of survey respondents reported that they have one or more ASQ certifications, and 25 percent said they hold two or more ASQ certifications. While certifications and training enable quality professionals to gain new skills and proficiencies, they can also greatly increase a quality professional’s earning power.
- Managers who are ASQ Certified Managers of Quality/Organizational Excellence reported they earn a higher average salary than their counterparts without this certification. In the United States, the difference is $7,938. In Canada, the difference is $3,274.
- Auditors who are Certified Quality Auditors make on average $15,451 more than those auditors who are not certified. In Canada, the difference is $12,839.
- The top ASQ certifications are Certified Quality Auditor (CQA) and Certified Quality Engineer (CQE).
The value of Six Sigma training has also held up well over the past several years. In particular, those in the United States with Master Black Belt (MBB) training earned a premium of more than $20,000 compared to those who stopped at Black Belt training.
“We are encouraged that quality professionals are gaining ground in terms of the recognition they are receiving for contributions to improving their organizations’ bottom lines,” said Paul Borawski, CEO of ASQ. “It’s clear that ASQ certifications and training provide a professional credibility and marketability that is helping quality professionals to gain a competitive edge in a volatile economy.”
This recent survey underscores that while quality professionals have not been immune to the economic recession, there are an expanding number of opportunities for professional growth.
For 24 years, ASQ has released its Annual Salary Survey, an indicator of the health of the quality profession using salary results. The survey breaks down salary information, submitted by ASQ members, into 24 categories such as job title, education, years of experience, and geographic location. A total of 5,348responses were received this year, the vast majority coming from professionals who work in the United States and Canada.
ASQ (www.asq.org) is a global community of people dedicated to quality who share the ideas and tools that make our world work better. With millions of individual and organizational members of the community in 150 countries, ASQ has the reputation and reach to bring together the diverse quality champions who are transforming the world’s corporations, organizations and communities to meet tomorrow’s critical challenges. ASQ is headquartered in Milwaukee, Wis., with national service centers in China, India and Mexico. Learn more about ASQ’s members, mission, technologies and training at www.asq.org.
French Drugmaker on Trial for Suspected DeathsFrom Yahoo! News
Servier Laboratories, French drugmaker responsible for producing diabetes and weight loss drug Mediator, faces charges for deception in relation to the suspected deaths of hundreds of people.
Novo Acquires Xellia Pharmaceuticals for $700 MillionFrom PharmaTimes Online
Novo A/S has acquired Xellia Pharmaceuticals of Norway
Royalty Increases Bid as Elan Unveils AcquisitionsFrom PharmaTimes Online
Royalty Pharma has resurfaced to raise its bid to acquire the Irish drugmaker Elan
New Asthma Drug Offers Hope for PatientsFrom Forbes
An experimental asthma drug could give new hope to patients for whom existing medicines are not enough
Syrian Pharma Production Nearly Halted by WarFrom AFP
A shortage of foreign currency has brought production to a near halt in Syria
Camfil APC Opens Manufacturing Plant in the UKFrom Camfil
Camfil announced the grand opening of its new 40,000-sq.-ft. facility
Actavis Acquiring Warner Chilcott for $8.5BFrom AP
Actavis to buy Warner Chilcott in an all-stock transaction
Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence SolutionFrom Northwest Analytics
NWA Focus EMI Delivers Real Time Process Intelligence and Unique Accelerating Modules - a Shared Knowledge Base and Manufacturing-Centric Collaboration
Innovative Clinical Development Partnership Announced By Quintiles and Merck SeronoFrom MarketWatch.com
Agreement creates unique strategic collaboration for development and clinical trial execution
$15 Billion Myland Offer Rejected By ActavisFrom Bloomberg.com
Actavis has rejected drugmaker Mylan Inc's cash-and-stock offer for $15 billion. They have decided to continue talks to take over Warner Chilcott Plc instead, sources have said.
- All news »